CompoAtlas

CalDenx

Natural health product licensed in Canada

Licence holder
Nihon Zoushin Kenkyukai Canada Inc.
NPN or DIN-HM
80016030
Status
Active licence
Licence date
18 February 2010
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Cholécalciférol

Source : Cholécalciférol

7.5 microgrammesNot calculated
Phytomenadione

Source : Phytomenadione

40 microgrammesNot calculated
Boron

Source : Sodium borate

200 microgrammesNot calculated
Calcium

Source : Citrate de calcium

300 milligramme900,000 µg
Calcium

Source : Carbonate de calcium

300 milligramme900,000 µg
Chrome

Source : Chlorure chromique

15 microgrammesNot calculated
Magnésium

Source : Oxyde de magnésium

75 milligramme225,000 µg
Folate

Source : Folate

60 microgrammesNot calculated

Non-medicinal ingredients

Poly(sorbate) 80, Cire de Carnauba, Poly(éthylène glycol), Acide stéarique, Hydroxypropylcellulose, Dioxyde de titanium, Sodium Citrate Dihydrate, Hypromellose, Cellulose, microcristalline, Stéarate de calcium, Dioxyde de silicium, Croscarmellose de sodium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Multi-vitamin/Mineral Supplement. Calcium, vitamin D, and magnesium help in the development and maintenance of bones and teeth. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80016030

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line